Related Experiment Video
Updated: May 4, 2026
14:47
Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
9.6K
Transcriptional Co-Activator With PDZ Binding Motif (TAZ) Inhibits Dexamethasone-Induced Muscle Atrophy via mTOR
Kyung Min Kim1, Ho Taek Oh1, Youjin Do1
1Division of Life Sciences, Korea University, Seoul, South Korea.
Journal of Cachexia, Sarcopenia and Muscle
|March 31, 2025
Summary
Dexamethasone causes muscle atrophy by decreasing TAZ levels. Stabilizing TAZ or using Ginsenoside Rb3 can prevent this, suggesting TAZ as a drug target for muscle wasting.
Area of Science:
- Biochemistry
- Molecular Biology
- Physiology
Background:
- Glucocorticoid therapy, while beneficial, can cause muscle atrophy (loss of muscle mass, size, and strength).
- The precise mechanisms underlying dexamethasone-induced muscle atrophy are not fully understood.
- This study investigates the role of the transcriptional co-activator with PDZ binding motif (TAZ) in this process.
Purpose of the Study:
- To elucidate the mechanism of dexamethasone-induced muscle atrophy.
- To determine the role of TAZ in dexamethasone-induced muscle atrophy.
- To explore potential therapeutic strategies targeting TAZ.
Main Methods:
- Muscle atrophy was induced in C2C12 myotubes and mice using dexamethasone.
- TAZ levels were analyzed using immunofluorescence, immunoblotting, and qRT-PCR.
- Adeno-associated virus was used for TAZ overexpression, and protein-protein interactions were studied.
Main Results:
- Dexamethasone treatment significantly decreased TAZ levels in both cell cultures and mice.
- Overexpression of a TAZ mutant resistant to degradation inhibited dexamethasone-induced muscle atrophy.
- Atrogin-1 and MuRF1 were found to interact with and degrade TAZ.
- Ginsenoside Rb3 treatment increased TAZ levels, stimulated mTOR signaling, and inhibited muscle atrophy.
Conclusions:
- TAZ plays a critical role in regulating dexamethasone-induced muscle atrophy.
- Stabilizing TAZ in muscle cells can ameliorate muscle atrophy.
- TAZ represents a potential therapeutic target for treating dexamethasone-induced muscle atrophy.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
8.9K
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.5K
Related Concept Videos
02:04Co-activators and Co-repressors
7.0K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.0K
02:23Master Transcription Regulators
6.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
01:22PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K